SRPT Stock Pops On Roche Licensing Deal For Gene Therapy - Investor's Business Daily

1. SRPT Stock Pops On Roche Licensing Deal For Gene Therapy  Investor's Business Daily
2. Roche dives deeper into gene therapy with $1.15 billion Sarepta licensing deal  Yahoo Finance
3. Roche to pay Sarepta $1B upfront for DMD gene therapy rights  FierceBiotech
4. Sarepta Stock Is Soaring on $1 Billion Deal With Roche  Barron's
5. Sarepta, Roche Strike Gene Therapy Licensing Agreement Worth Up To $2.85B  Yahoo Finance
6. View full coverage on Google News

SRPT Stock Pops On Roche Licensing Deal For Gene Therapy - Investor's Business Daily
Read More


Bagikan Berita Ini